SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001437749-20-013535
Filing Date
2020-06-22
Accepted
2020-06-22 13:25:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 8308
2 logo1.jpg GRAPHIC 561130
3 logo2.jpg GRAPHIC 561821
  Complete submission text file 0001437749-20-013535.txt   1547296
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances